Medical Condition News

RSS

NCI investigators design genetically engineered mouse to study human lung squamous cell carcinoma

National Cancer Institute (NCI) investigators have designed a genetically engineered mouse for use in the study of human lung squamous cell carcinoma (SCC). SCC is a type of non-small cell lung carcinoma, one of the most common types of lung cancer, with a five-year survival rate of about 15 percent.

18 Apr 2013

Mentally vulnerable people face increase risk of fatal and non-fatal cardiovascular disease

People deemed to be "mentally vulnerable" are at a significantly increased risk of both fatal and non-fatal cardiovascular disease, according to results of a large population study from Denmark. The details of the study were presented today at the EuroPRevent 2013 congress in Rome.

18 Apr 2013

Studies suggest physically demanding work is a risk factor for coronary heart disease

Two studies presented at this year's EuroPRevent 2013 congress suggest that demanding physical work has a detrimental effect on an individual's risk of coronary heart disease.

18 Apr 2013

Study indicates multispectral photoacoustic imaging can distinguish between benign and malignant prostate tissue

Multispectral photoacoustic imaging, which combines laser optics and ultrasound imaging technologies, can reliably distinguish between benign and malignant prostate tissue, a new study indicates.

18 Apr 2013

New report reveals growing burden of osteoporosis in all 27 member states of EU

A new report prepared in collaboration with the International Osteoporosis Foundation and the European Federation of Pharmaceutical Industry Associations, is the first to describe in detail the epidemiology, burden, and treatment of osteoporosis in all 27 member states of the European Union.

18 Apr 2013

New combination therapies with anti-sickling capabilities needed for sickle cell disease

Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.

18 Apr 2013

New study finds newspapers are paying more attention to the long-term impact of concussions

Newspapers are paying more attention to the severity and long-term impact of concussions and other traumatic brain injuries in ice hockey than they did 25 years ago, a new study has found.

18 Apr 2013

Beaumont Health System recognized for helping children, adults with special needs

Beaumont Health System's participation in Project SEARCH was recently recognized by The Arc of Oakland County with its "Employer/Contractor of the Year Award."

18 Apr 2013

New review of medications to prevent migraines appears in Journal of General Internal Medicine

Migraine headaches are a major cause of ill health and a reduced quality of life. Some individuals suffer from a frequent and severe migraine problem which means that they require regular medication to try and prevent them.

18 Apr 2013

Running or jumping may worsen cartilage damage, MIT engineers find

Osteoarthritis, which affects at least 20 percent of adults in the United States, leads to deterioration of cartilage, the rubbery tissue that prevents bones from rubbing together.

18 Apr 2013

ESCEO and IOF honor Dr. Mary L. Bouxsein with ESCEO-IOF Herbert Fleisch Medal

Dr. Mary L. Bouxsein has been awarded the ESCEO-IOF Herbert Fleisch Medal in honor of her work in the field of skeletal fragility.

18 Apr 2013

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.

18 Apr 2013

Telemedicine house calls for Parkinson’s patients: an interview with Dr Ray Dorsey, Johns Hopkins University

Access to neurological care for Parkinson disease is currently limited by distance, disability, and the distribution of doctors.

18 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Eli Lilly reports positive results from Phase III AWARD trials of type 2 diabetes drug, dulaglutide

Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.

18 Apr 2013

Mast Therapeutics' data show that MST-188 reduces aggregation of both older and younger RBC

Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.

18 Apr 2013

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

Scientists from academic institutions reported at the 2013 annual American Association for Cancer Research meeting, results from preclinical studies which showed that certain bladder cancers and mesotheliomas have metabolic changes and are more likely to respond to treatment with ADI-PEG 20 (pegylated arginine deiminase) if they are deficient in the enzyme, argininosuccinate synthetase.

18 Apr 2013

UTHealth neuroscientists demonstrate new strategy to overcome memory deficits

Neuroscientists at The University of Texas Health Science Center at Houston have taken a major step in their efforts to help people with memory loss tied to brain disorders such as Alzheimer's disease.

18 Apr 2013

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

The Korea-based international pharmaceutical company, SK Biopharmaceuticals, announced today the U.S. Food and Drug Administration has authorized the Investigational New Drug application for SKL15508 to treat cognitive impairment associated with schizophrenia.

18 Apr 2013

Study: Patients who suffer STEMI heart attacks while hospitalized are 10 times more likely to die

If you suffer a heart attack while walking down the street and are taken to the hospital quickly, your chances of survival are very good. But if you have a heart attack while already in the hospital for something else, you are 10 times more likely to die.

18 Apr 2013

Medical Condition News

NCI investigators design genetically engineered mouse to study human lung squamous cell carcinoma

Mentally vulnerable people face increase risk of fatal and non-fatal cardiovascular disease

Studies suggest physically demanding work is a risk factor for coronary heart disease

Study indicates multispectral photoacoustic imaging can distinguish between benign and malignant prostate tissue

New report reveals growing burden of osteoporosis in all 27 member states of EU

New combination therapies with anti-sickling capabilities needed for sickle cell disease

New study finds newspapers are paying more attention to the long-term impact of concussions

Beaumont Health System recognized for helping children, adults with special needs

New review of medications to prevent migraines appears in Journal of General Internal Medicine

Running or jumping may worsen cartilage damage, MIT engineers find

ESCEO and IOF honor Dr. Mary L. Bouxsein with ESCEO-IOF Herbert Fleisch Medal

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

Telemedicine house calls for Parkinson’s patients: an interview with Dr Ray Dorsey, Johns Hopkins University

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Eli Lilly reports positive results from Phase III AWARD trials of type 2 diabetes drug, dulaglutide

Mast Therapeutics' data show that MST-188 reduces aggregation of both older and younger RBC

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

UTHealth neuroscientists demonstrate new strategy to overcome memory deficits

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

Study: Patients who suffer STEMI heart attacks while hospitalized are 10 times more likely to die

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News